Home›Companies›Industrial & Robotics›Bloom Labs Bio

Bloom Labs Bio Inc.

Updated Oct 29, 2026·Latest SEC filing Jan 8, 2024·Suggest an edit

About Bloom Labs Bio

Bloom Labs Bio is a private company based in New York, New York. It has reported $2,805,350 raised in one offering on Form D since January 2024. Its chief executive is Simardev Gulati.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 31, 2016Jan 8, 2024$2,805,350target not set28$100KDebt, Options, Convertible NoteRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Bloom Labs Bio's Form D filed Jan 8, 2024.

SG
Simardev Gulati
CEO and director

Sources

  1. SECBloom Labs Bio Inc. filing history